Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy

Lasers in Medical Science

Volumn 24, Issue 5, 2009, Pages 729-734

  MacKenzie, Gary D ^a   Dunn, Jason M ^a   Selvasekar, C R ^a   Mosse, C Alexander ^a   Thorpe, Sally M ^a   Novelli, Marco R ^a   Bown, Stephen G ^a   Lovat, Laurence B ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Aminolaevulinic acid; Barrett's oesophagus; Cancer; High grade dysplasia; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID;

ARTICLE; BARRETT ESOPHAGUS; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ENDOSCOPY; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

AMINOLEVULINIC ACID; BARRETT ESOPHAGUS; ESOPHAGUS; HUMANS; KAPLAN-MEIER ESTIMATE; LASERS; OPTICAL PHENOMENA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RECURRENCE;

EID: 68849090310     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10103-008-0630-7     Document Type: Article

References (27)

1. A Newnham MJ Quinn P Babb 2003 Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998 Aliment Pharmacol Ther 17 665 676 (Pubitemid 36418890)
2. E Montgomery JR Goldblum JK Greenson 2001 Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study Hum Pathol 32 379 388
3. BJ Reid DS Levine G Longton 2000 Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol 95 1669 1676
4. TG Schnell SJ Sontag G Chejfec 2001 Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 1607 1619
5. BF Overholt KK Wang JS Burdick 2007 Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia Gastrointest Endosc 66 460 468
6. BF Overholt M Panjehpour JM Haydek 1999 Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients Gastrointest Endosc 49 1 7
7. BF Overholt M Panjehpour DL Halberg 2003 Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results Gastrointest Endosc 58 183 188
8. CS Loh AJ MacRobert G Buonaccorsi 1996 Mucosal ablation using photodynamic therapy for the treatment of dysplasia: an experimental study in the normal rat stomach Gut 38 71 78
9. J Regula AJ MacRobert A Gorchein 1995 Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX-a pilot study Gut 36 67 75
10. Mackenzie GD, Jamieson NF, Novelli MR et al (2008) How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus. Lasers Med Sci 23:203-210
11. R Ackroyd CJ Kelty NJ Brown 2003 Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up Endoscopy 35 496 501
12. F Peters M Kara W Rosmolen 2005 Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection Endoscopy 37 418 424
13. RJ Schlemper RH Riddell Y Kato 2000 The Vienna classification of gastrointestinal epithelial neoplasia Gut 47 251 255
14. R Waidelich H Stepp R Baumgartner 2001 Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer J Urol 165 1904 1907
15. R Ackroyd NJ Brown MF Davis 2000 Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus Dis Esophagus 13 18 22
16. O Pech L Gossner A May 2005 Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia Gastrointest Endosc 62 24 30
17. FP Peters MA Kara WD Rosmolen 2005 Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus Gastrointest Endosc 61 506 514
18. H Barr NA Shepherd A Dix 1996 Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX Lancet 348 584 585
19. DG Forcione T Hasan BJ Ortel 2004 Optimization of aminolevulinic acid-based photodynamic therapy of Barrett's esophagus with high grade dysplasia Gastrointest Endosc 59 P251
20. M Hage PD Siersema H van Dekken 2004 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial Gut 53 785 790
21. L Gossner M Stolte R Sroka 1998 Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid Gastroenterology 114 448 455
22. CJ Kelty R Ackroyd NJ Brown 2004 Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation Aliment Pharmacol Ther 20 1289 1296
23. CJ Kelty R Ackroyd NJ Brown 2004 Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus Surg Endosc 18 452 458
24. R Ackroyd NJ Brown MF Davis 2000 Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial Gut 47 612 617
25. GD Mackenzie JM Dunn MR Novelli 2008 Preliminary results of a randomised controlled trial into the safety and efficacy of ala versus photofrin photodynamic therapy for high grade dysplasia in Barrett's oesophagus Gut 57 A14
26. VK Sharma KK Wang BF Overholt 2007 Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients Gastrointest Endosc 65 185 195
27. RI Rothstein K Chang BF Overholt 2007 Focal ablation for treatment of dysplastic and non-dysplastic Barrett esophagus: safety profile and initial experience with the Halo90 device in 508 cases Gastrointest Endosc 65 AB147